© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
January 30, 2020
The combination treatment of Tecentriq (atezolizumab) and Avastain (bevacizumab) improved patient-reported outcomes and quality of life in a recent phase 3 study.
Roundup Herbicide Will Ditch Glyphosate, the Chemical Linked to Cancer
Keeping Faith After a Sarcoma Diagnosis
Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being
Why Isn’t Sunscreen Marketed to Men?